More Popular Issues
See how voters are siding on other popular political issues...
Last answered 1 hour ago
Distribution of answers submitted by Australian voters.
No, limiting drug prices would also limit the investment in research and development into new life-saving drugs
Data includes total votes submitted by visitors since Sep 6, 2016. For users that answer more than once (yes we know), only their most recent answer is counted in the total results. Total percentages may not add up to exactly 100% as we allow users to submit "grey area" stances that may not be categorised into yes/no stances.
Choose a demographic filter
Data based on 30-day moving average to reduce daily variance from traffic sources. Totals may not add up to exactly 100% as we allow users to submit "grey area" stances that may not be categorized into yes/no stances.
Learn more about Drug Price Regulation
The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. Proponents of drug price regulation argue that drug makers raise prices to benefit the value of their stock and invest little of their profits in the development and research of new drugs. Opponents of regulation argue that consumers rely on drug companies to develop new drugs and limiting prices will prevent new lifesaving drugs from being developed. See recent drug price regulation news